V-WAVE
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
V-WAVE
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2010-01-01
Address:
Caesarea, Hefa, Israel
Country:
Israel
Website Url:
http://www.vwavemedical.com
Total Employee:
51+
Status:
Active
Contact:
+972 77 316 8550
Total Funding:
226 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Mobile Non Scaleable Content ReCAPTCHA Contact Form 7 WordPress 6.4 ASP.NET
Similar Organizations
Brighter
Data-driven solutions for smarter treatment of chronic conditions.
Magenta Medical
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Medtrum
Medtrum is a diabetes management medical device developer.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
keepMED
keepMED is developing a new device for the treatment of Obstructive Sleep Apnea
NuPulseCV
NuPulse specializes in developing technology designed to treat patients with heart failure.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
DiNovA Medtech
DiNovA Medtech develops vascular intervention technology for the treatment of aneurysm.
Current Employees Featured
Neal Eigler MD & CEO @ V-Wave
MD & CEO
Willam T. Abraham CMO @ V-Wave
CMO
Erez Rozenfeld President @ V-Wave
President
2013-01-01
Murtaza Mogri Director, Business Development and Market Access @ V-Wave
Director, Business Development and Market Access
2017-01-01
Dudy Stolick Vice President Finance @ V-Wave
Vice President Finance
2018-08-01
William T. Abraham Chief Medical Officer @ V-Wave
Chief Medical Officer
2019-01-01
Founder
Investors List
Deerfield
Deerfield investment in Series C - V-Wave
Pontifax
Pontifax investment in Series C - V-Wave
Pura Vida Investments
Pura Vida Investments investment in Series C - V-Wave
Quark Venture
Quark Venture investment in Series C - V-Wave
Triventures
Triventures investment in Series C - V-Wave
Israel Secondary Fund (ISF)
Israel Secondary Fund (ISF) investment in Series C - V-Wave
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series C - V-Wave
Endeavour Vision
Endeavour Vision investment in Series C - V-Wave
Aperture Venture Partners
Aperture Venture Partners investment in Series C - V-Wave
BRM Capital
BRM Capital investment in Series C - V-Wave
Official Site Inspections
http://www.vwavemedical.com Semrush global rank: 4.87 M Semrush visits lastest month: 1.77 K
- Host name: cloudproxy10115.sucuri.net
- IP address: 192.124.249.115
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "V-Wave"
V-WAVE® | Advancing the Flow of Life
At V-WAVE, we are driven to deliver breakthrough ideas and technology to the healthcare world with a focus on cardiovascular disease. V-Wave is built on a foundation of science, …See details»
Johnson & Johnson to Acquire V-Wave | V-WAVE®
NEW BRUNSWICK, N.J.— August 20, 2024 – Johnson & Johnson 1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately …See details»
About V-WAVE | V-WAVE®
Technology designed by V-Wave, highlighted by its Ventura® Interatrial Shunt System, was designed to help heart failure patients with relief of symptoms, reduced hospitalizations, and …See details»
V-Wave - LinkedIn
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic …See details»
V-Wave - Crunchbase Company Profile & Funding
V-Wave is a medical device company that develops percutaneous implantable devices for patients with chronic heart failure. View contacts for V-Wave to access new leads and connect …See details»
Johnson & Johnson to Acquire V-Wave - Morningstar
Aug 20, 2024 · Johnson & Johnson 1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing …See details»
William T. Abraham, MD, joins V-Wave as Chief Medical Officer
CAESAREA, Israel, March 12, 2019 /PRNewswire/ — V-Wave Ltd., an early stage medtech company developing an implantable interatrial shunt device for treating advanced heart failure …See details»
V-Wave Completes Financing of Up to $98M from Syndicate of …
Sep 22, 2020 · CAESAREA, Israel and AGOURA HILLS, Calif., Sept. 22, 2020 /PRNewswire/ -- V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive …See details»
Leadership | V-WAVE®
Dr. Neal Eigler joined V-Wave as its CEO in early 2015 and has since overseen the development of the company’s senior management team, the evolution of its shunt products and …See details»
William T. Abraham, MD, joins V-Wave as Chief Medical Officer
CAESAREA, Israel, March 12, 2019 /PRNewswire/ -- V-Wave Ltd., an early stage medtech company developing an implantable interatrial shunt device for treating advanced heart failure …See details»
V-Wave's Interatrial Shunt Receives FDA Breakthrough Device
Aug 15, 2019 · V-Wave's minimally invasive, implanted interatrial shunt is being evaluated in a global, randomized, controlled, double-blinded, 500 patient pivotal IDE trial called RELIEVE-HF.See details»
Israeli cardiovascular device developer V-Wave raises $98 million
Sep 23, 2020 · V-Wave, an Israel-based company that has developed a minimally invasive implanted shunt device for treating patients with severe symptomatic heart failure has raised …See details»
V-Wave's Interatrial Shunt Receives FDA Breakthrough Device …
Aug 15, 2019 · V-Wave Ltd. is an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe …See details»
Johnson & Johnson to Acquire V-Wave | J&J MedTech
NEW BRUNSWICK, N.J.— August 20, 2024 – Johnson & Johnson 1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately …See details»
V-Wave Company Profile, Investors, & Funding - Lucidity Insights
Jul 3, 2013 · V-WAVE was established in Israel with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V …See details»
V-WAVE RECEIVES SECOND FDA BREAKTHROUGH DEVICE …
Sep 12, 2019 · V-Wave Ltd., a privately held medical device company developing novel implantable devices for the treatment of Heart Failure (HF), today announced that its …See details»
V-Wave Receives Second FDA Breakthrough Device Designation: …
Sep 12, 2019 · V-Wave is testing a minimally invasive, implanted interatrial shunt device for PAH in a global approved IDE Early Feasibility Study, RELIEVE-PAH.See details»
Johnson & Johnson to Acquire V-Wave
NEW BRUNSWICK, N.J.— August 20, 2024 – Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately …See details»
V-WAVE COMPLETES FINANCING OF $98M FROM SYNDICATE OF …
Dec 16, 2021 · Funds Support Completion of Pivotal Clinical Trial of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure. Location: Caesarea, Israel and Agoura California.See details»
Privacy Policy | V-WAVE® - vwavemedical.com
Apr 21, 2021 · Whilst we do not change our practices in response to a “Do Not Track” signal in the HTTP header from a browser or mobile application, you can manage your cookies …See details»